Northern Trust’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,744
| Closed | -$25.2K | – | 4502 |
|
|
2023
Q4 | $25.2K | Hold |
3,744
| – | – | ﹤0.01% | 4335 |
|
|
2023
Q3 | $34.3K | Sell |
3,744
-667
| -15% | -$6.1K | ﹤0.01% | 4247 |
|
|
2023
Q2 | $93.2K | Sell |
4,411
-8,968
| -67% | -$189K | ﹤0.01% | 4055 |
|
|
2023
Q1 | $360K | Sell |
13,379
-246
| -2% | -$6.62K | ﹤0.01% | 3589 |
|
|
2022
Q4 | $482K | Buy |
13,625
+220
| +2% | +$7.79K | ﹤0.01% | 3519 |
|
|
2022
Q3 | $3.03M | Buy |
13,405
+302
| +2% | +$68.2K | ﹤0.01% | 2780 |
|
|
2022
Q2 | $2.48M | Buy |
13,103
+2,327
| +22% | +$440K | ﹤0.01% | 2933 |
|
|
2022
Q1 | $2.68M | Sell |
10,776
-398
| -4% | -$99.1K | ﹤0.01% | 2947 |
|
|
2021
Q4 | $1.74M | Sell |
11,174
-228
| -2% | -$35.5K | ﹤0.01% | 3289 |
|
|
2021
Q3 | $2.29M | Sell |
11,402
-436
| -4% | -$87.4K | ﹤0.01% | 3219 |
|
|
2021
Q2 | $3.03M | Sell |
11,838
-614
| -5% | -$157K | ﹤0.01% | 3150 |
|
|
2021
Q1 | $3.31M | Sell |
12,452
-1,929
| -13% | -$512K | ﹤0.01% | 2996 |
|
|
2020
Q4 | $5.3M | Buy |
14,381
+588
| +4% | +$217K | ﹤0.01% | 2656 |
|
|
2020
Q3 | $3.37M | Buy |
13,793
+872
| +7% | +$213K | ﹤0.01% | 2767 |
|
|
2020
Q2 | $3.72M | Buy |
12,921
+2,190
| +20% | +$631K | ﹤0.01% | 2695 |
|
|
2020
Q1 | $2.19M | Buy |
10,731
+616
| +6% | +$126K | ﹤0.01% | 2805 |
|
|
2019
Q4 | $4.52M | Buy |
10,115
+167
| +2% | +$74.6K | ﹤0.01% | 2644 |
|
|
2019
Q3 | $3.06M | Buy |
9,948
+6,986
| +236% | +$2.15M | ﹤0.01% | 2847 |
|
|
2019
Q2 | $942K | Buy |
2,962
+1,083
| +58% | +$344K | ﹤0.01% | 3378 |
|
|
2019
Q1 | $788K | Sell |
1,879
-146
| -7% | -$61.2K | ﹤0.01% | 3432 |
|
|
2018
Q4 | $617K | Buy |
2,025
+447
| +28% | +$136K | ﹤0.01% | 3507 |
|
|
2018
Q3 | $568K | Buy |
1,578
+226
| +17% | +$81.3K | ﹤0.01% | 3607 |
|
|
2018
Q2 | $495K | Buy |
1,352
+373
| +38% | +$137K | ﹤0.01% | 3600 |
|
|
2018
Q1 | $289K | Buy |
979
+616
| +170% | +$182K | ﹤0.01% | 3719 |
|
|
2017
Q4 | $152K | Buy |
+363
| New | +$152K | ﹤0.01% | 3891 |
|
|
2017
Q2 | – | Sell |
-1,374
| Closed | -$472K | – | 4308 |
|
|
2017
Q1 | $472K | Buy |
1,374
+107
| +8% | +$36.8K | ﹤0.01% | 3557 |
|
|
2016
Q4 | $443K | Buy |
1,267
+27
| +2% | +$9.44K | ﹤0.01% | 3558 |
|
|
2016
Q3 | $498K | Buy |
1,240
+116
| +10% | +$46.6K | ﹤0.01% | 3514 |
|
|
2016
Q2 | $668K | Buy |
+1,124
| New | +$668K | ﹤0.01% | 3452 |
|
|
2016
Q1 | – | Sell |
-75
| Closed | -$49K | – | 4296 |
|
|
2015
Q4 | $49K | Hold |
75
| – | – | ﹤0.01% | 4048 |
|
|
2015
Q3 | $35K | Buy |
75
+17
| +29% | +$7.93K | ﹤0.01% | 4132 |
|
|
2015
Q2 | $33K | Buy |
58
+19
| +49% | +$10.8K | ﹤0.01% | 4110 |
|
|
2015
Q1 | $332K | Buy |
39
+2
| +5% | +$17K | ﹤0.01% | 3728 |
|
|
2014
Q4 | $329K | Buy |
37
+3
| +9% | +$26.7K | ﹤0.01% | 3680 |
|
|
2014
Q3 | $162K | Sell |
34
-98
| -74% | -$467K | ﹤0.01% | 3898 |
|
|
2014
Q2 | $952K | Buy |
132
+78
| +144% | +$563K | ﹤0.01% | 3413 |
|
|
2014
Q1 | $290K | Buy |
+54
| New | +$290K | ﹤0.01% | 3689 |
|